✦ LIBER ✦

PSN2 COST-EFFECTIVENESS ANALYSIS: ALDARA™ (IMIQUIMOD) CREAM, 5% IN THE TREATMENT OF SUPERFICIAL BASAL CELL CARCINOMA IN NORWAY

✍ Scribed by JM Sverre; FKO Kristensen; L Hamel-Gariépy; T Albrektsen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PSN4 COST-EFFECTIVENESS MODEL OFALDARA™

✍ E De Cock; MJ Nuijten; A Hollestein; L Hamel-Gariépy 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Cost-effectiveness of treatment of super

✍ F. Vanaclocha; E. Daudén; X. Badía; C. Guillén; J.S. Conejo-Mir; M. Sainz de los 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Imiquimod 5% cream in the treatment of m

✍ Michael Freeman; Greg Siller; Shan Edwards; Mark Amies 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 58 KB

PCN17 COST EFFECTIVENESS OF IMIQUIMOD IN

✍ Karve, S; Pearce, D; Yentzer, BA; Feldman, SR; Balkrishnan, R 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Efficacy of imiquimod 5% cream in the tr

✍ John Geisse; Ivor Caro; Jane Lindholm; Loren Golitz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Imiquimod 5% cream in the treatment of s

✍ Robin Marks; Kurt Gebauer; Stephen Shumack; Mark Amies; James Bryden; Terry L. F 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 123 KB